SCHEMBL3853355

SCHEMBL3853355

OC1(c2cccc(C(F)(F)F)c2F)CCN(CCCF)CC1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DRD2 P14416 11/20 0.43
CCR1 P32246 2/20 0.42
OPRM1 P35372 8/20 0.42
HTR1A P08908 7/20 0.42
DRD4 P21917 7/20 0.42
HTR2A P28223 7/20 0.42
HTR2C P28335 7/20 0.42
HTR7 P34969 7/20 0.42
OPRK1 P41145 7/20 0.42
HTR1D P28221 6/20 0.42
HRH2 P25021 6/20 0.42
DRD3 P35462 6/20 0.42
HTR2B P41595 6/20 0.42
DRD1 P21728 5/20 0.42
DRD5 P21918 5/20 0.42
SLC6A2 P23975 5/20 0.42
SLC6A4 P31645 5/20 0.42
OPRD1 P41143 5/20 0.42
HTR6 P50406 5/20 0.42
SLC6A3 Q01959 5/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3851753 0.89 UBE2M (0.45) DRD2CCR1OPRM1HTR1ADRD4
SCHEMBL3853965 0.86 OPRM1 (0.43) DRD2CCR1OPRM1HTR1ADRD4
SCHEMBL2783423 0.86 LMNA (0.44) DRD2CCR1OPRM1HTR1ADRD4
SCHEMBL3772165 0.83 OPRL1 (0.39) DRD2CCR1OPRM1OPRK1OPRD1
SCHEMBL3853446 0.83 DRD2 (0.42) DRD2CCR1OPRM1HTR1ADRD4
SCHEMBL3769750 0.81 OPRD1 (0.38) OPRM1OPRK1OPRD1CYP3A4CYP2D6
SCHEMBL5501040 0.80 FPR3 (0.40) DRD2CCR1OPRM1HTR1ADRD4
SCHEMBL3856190 0.75 OPRM1 (0.43) OPRM1OPRK1OPRD1CYP2D6OPRL1
SCHEMBL2783267 0.75 NOTUM (0.41) OPRM1OPRK1OPRD1OPRL1
SCHEMBL3856503 0.75 DRD2 (0.65) DRD2CCR1DRD4DRD3SIGMAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101076517-B Substituted piperidines as modulators of dopamine neurotransmission NSAB AF NEUROSEARCH SWEDEN AB 2010-12-15 CN disclosed
EP-1765779-B1 NEW SUBSTITUTED PIPERIDINES AS MODULATORS OF DOPAMINE NEUROTRANSMISSION NSAB AF NEUROSEARCH SWEDEN AB (DK) 2009-11-18 EP disclosed
US-7579474-B2 Substituted piperidines as modulators of dopamine neurotransmission NSAB, FILIAL AF NEUROSEARCH AB, SVERIGE (DK) 2009-08-25 US disclosed
US-20070270467-A1 SUBSTITUTED PIPERIDINES AS MODULATORS OF DOPAMINE NEUROTRANSMISSION NSAB, FILIAL AF NEUROSEARCH SWEDEN AB, SVERIGE (DK) 2007-11-22 US disclosed
CN-101076517-A Novel substituted piperidines as modulators of dopamine neurotransmission CARLSSON A RESEARCH AB (SE) 2007-11-21 CN disclosed
EP-1765779-A1 NEW SUBSTITUTED PIPERIDINES AS MODULATORS OF DOPAMINE NEUROTRANSMISSION A. CARLSSON RESEARCH AB (SE) 2007-03-28 EP disclosed
WO-2005121092-A1 NEW SUBSTITUTED PIPERIDINES AS MODULATORS OF DOPAMINE NEUROTRANSMISSION A. CARLSSON RESEARCH AB (SE) 2005-12-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070270467-A1 SUBSTITUTED PIPERIDINES AS MODULATORS OF DOPAMINE NEUROTRANSMISSION DRD2, PRLHR, DRD3 DRD2 1/4885CCR1 2632/4885OPRM1 35/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.